Citation
Wang, Yucheng, et al. "Identification of Prototypes From Ligustri Lucidi Fructus in Rat Plasma Based On a Data-dependent Acquisition and Multicomponent Pharmacokinetic Study." Biomedical Chromatography : BMC, vol. 34, no. 7, 2020, pp. e4833.
Wang Y, Feng K, Li M, et al. Identification of prototypes from Ligustri Lucidi Fructus in rat plasma based on a data-dependent acquisition and multicomponent pharmacokinetic study. Biomed Chromatogr. 2020;34(7):e4833.
Wang, Y., Feng, K., Li, M., Han, L., Wang, W., Si, D., Chen, X., Yang, W., Gao, X., & Liu, E. (2020). Identification of prototypes from Ligustri Lucidi Fructus in rat plasma based on a data-dependent acquisition and multicomponent pharmacokinetic study. Biomedical Chromatography : BMC, 34(7), e4833. https://doi.org/10.1002/bmc.4833
Wang Y, et al. Identification of Prototypes From Ligustri Lucidi Fructus in Rat Plasma Based On a Data-dependent Acquisition and Multicomponent Pharmacokinetic Study. Biomed Chromatogr. 2020;34(7):e4833. PubMed PMID: 32198769.
TY - JOUR
T1 - Identification of prototypes from Ligustri Lucidi Fructus in rat plasma based on a data-dependent acquisition and multicomponent pharmacokinetic study.
AU - Wang,Yucheng,
AU - Feng,Keyu,
AU - Li,Mengrong,
AU - Han,Lifeng,
AU - Wang,Weiqiang,
AU - Si,Dandan,
AU - Chen,Xiaopeng,
AU - Yang,Wenzhi,
AU - Gao,Xiumei,
AU - Liu,Erwei,
Y1 - 2020/04/20/
PY - 2020/01/14/received
PY - 2020/02/26/revised
PY - 2020/03/13/accepted
PY - 2020/3/22/pubmed
PY - 2021/4/1/medline
PY - 2020/3/22/entrez
KW - Ligustri Lucidi Fructus
KW - MS
KW - pharmacokinetics
KW - prototypes
SP - e4833
EP - e4833
JF - Biomedical chromatography : BMC
JO - Biomed Chromatogr
VL - 34
IS - 7
N2 - The identification and quantization of traditional Chinese medicine (TCM) are a challenge for researchers and industry. Using untargeted analytical methods, the in vivo detection and identification of TCM compounds are difficult because of the significant interference of endogenous substances. Fortunately, the ongoing development of new analytical technologies, especially Q-Orbitrap-MS, offers some solutions. Our team developed a holistic MS method, combining untargeted data-dependent MS2 (dd-MS2) modes to extensively identify TCM prototypes in vivo. The method was successfully applied to the analysis of Ligustri Lucidi Fructus (LLF). LLF is a widely used TCM with a remarkable nourishing effect on the liver and kidney. In the study, we aimed to identify the prototypes in rat plasma after oral administration of LLF extract. Following separation on an HSS T3 column, LLF extract and rat plasma were performed in untargeted dd-MS2 mode. Forty-seven compounds were characterized in rats plasma as prototypes of LLF extract. Furthermore, seven major prototypes were chosen as pharmacokinetic markers to investigate LLF's pharmacokinetic properties. The results provides comprehensive determination of compounds in LLF both in vitro and in vivo, which is important for quality control, pharmacology studies and clinical use of LLF.
SN - 1099-0801
UR - https://www.unboundmedicine.com/medline/citation/32198769/Identification_of_prototypes_from_Ligustri_Lucidi_Fructus_in_rat_plasma_based_on_a_data_dependent_acquisition_and_multicomponent_pharmacokinetic_study_
DB - PRIME
DP - Unbound Medicine
ER -